Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptic ulcer--a new look

J Y Kang1

  • 1Department of Medicine, National University Hospital, Singapore.

Annals of the Academy of Medicine, Singapore
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Advances in peptic ulcer disease treatment over 25 years include endoscopy, acid suppressors like histamine H-2 receptor antagonists, and identifying Helicobacter pylori as a key cause. Eradicating H. pylori offers a cure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinical effect of modified anterolateral acromioplasty in rotator cuff repair under shoulder arthroscope].

Zhonghua yi xue za zhi·2024
Same author

Impact of COVID-19 on TB services in Korea.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same author

Aberrant GATA2 epigenetic dysregulation induces a GATA2/GATA6 switch in human gastric cancer.

Oncogene·2017
Same author

Improved p-type conductivity in Al-rich AlGaN using multidimensional Mg-doped superlattices.

Scientific reports·2016
Same author

Asymmetric light reflectance from metal nanoparticle arrays on dielectric surfaces.

Scientific reports·2015
Same author

Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations.

Therapeutic advances in chronic disease·2015
Same journal

"Gazing into the crystal ball of mortality prediction in conservative kidney care": Correspondence.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Vascular stiffness and sepsis mortality: A promising signal in search of clinical relevance.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Transcatheter aortic valve implantation for severe aortic regurgitation with Trilogy system: Initial Southeast Asia experience.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Singapore expert consensus on optimising lipid-lowering strategies in acute coronary syndrome: A modified Delphi study.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Association of estimated pulse wave velocity with 28-day mortality in sepsis: A MIMIC-IV study.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Prognostic value of the monocyte-to-albumin ratio in nasopharyngeal carcinoma: A retrospective cohort study.

Annals of the Academy of Medicine, Singapore·2026
See all related articles

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Pharmacology

Background:

  • Peptic ulcer disease (PUD) management has evolved significantly over the past 25 years.
  • Flexible endoscopy revolutionized PUD diagnosis and facilitated clinical trials.
  • Histamine H-2 receptor antagonists were the first potent medical treatment for PUD.

Purpose of the Study:

  • To review major advancements in the diagnosis and treatment of peptic ulcer disease.
  • To highlight the impact of Helicobacter pylori and NSAIDs on PUD.
  • To discuss future directions in PUD management.

Main Methods:

  • Review of major advances in peptic ulcer disease over the last 25 years.
  • Discussion of diagnostic tools like flexible endoscopy.

Related Experiment Videos

  • Analysis of therapeutic agents including histamine H-2 receptor antagonists, colloidal bismuth, sucralfate, prostaglandin analogues, and omeprazole.

    • Main Results:

    • Flexible endoscopy enables accurate diagnosis and clinical trials.
    • Various effective ulcer healing agents have been introduced.
    • Helicobacter pylori is identified as the primary cause of PUD, with eradication leading to cures.
    • Non-steroidal anti-inflammatory drugs (NSAIDs) are the second leading cause of PUD and complications.

    Conclusions:

    • Helicobacter pylori eradication is key to curing PUD, though further research on its sequelae and optimal treatment is needed.
    • NSAID-induced ulcers pose significant risks; prophylaxis with misoprostol and H2 antagonists is possible but indications require definition.
    • Future PUD reduction may involve controlling H. pylori through socio-economic improvements or vaccines and developing safer NSAIDs.